clinical research

UK’s clinical research recovering slower than Euro peers, says ABPI

The pandemic had a negative effect on clinical research across all countries, but the UK seems to be taking longer than others to recover, according to a report from the Association of the British Pharmaceutical Industry (ABPI). The industry body maintains however that the UK can bounce back strongly if it adopts the innovative approaches …

UK’s clinical research recovering slower than Euro peers, says ABPI Read More »

AllStripes Secures $50M to Advance Global Rare Disease Research PlatforM

Nancy Yu, CEO and Co-founder, AllStripes – AllStripes, a San Francisco-based healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced it has raised $50 million in Series B funding led by Lux Capital, a current investor, joined by JAZZ Venture Partners, Spark Capital, Medidata Solutions, McKesson Ventures, and Maveron. The round also …

AllStripes Secures $50M to Advance Global Rare Disease Research PlatforM Read More »

Does draft RCT guide set the scene for future trials?

A common set of standards for randomised clinical trials (RCTs) aims to help researchers develop the drugs and interventions of the future – no matter what they do or where they are based. The Good Clinical Trials Collaborative (GCTC) has published a draft guidance document, and is asking for the life sciences sector to make …

Does draft RCT guide set the scene for future trials? Read More »

Arcus’ CMO Grossman jumps ship to join Gilead’s cancer push

Gilead Sciences just forged even closer ties with its cancer drug partner Arcus Biosciences, enticing the biotech’s chief medical officer Bill Grossman to a new role as its head of oncology clinical research. The two companies entered into a 10-year alliance last year, with Gilead claiming certain rights to Arcus clinical and preclinical immuno-oncology candidates …

Arcus’ CMO Grossman jumps ship to join Gilead’s cancer push Read More »

IQVIA adds to growing lab biz with $198M deal for Myriad contract services unit

IQVIA is paying nearly $200 million to purchase a Myriad Genetics subsidiary that provides pharmaceutical contract services , a deal that will put the new acquisition in the company’s Q2 Solutions unit, The deal follows IQVIA’s April announcement that it had secured full ownership of Q2, which had been a joint venture with Quest Diagnostics.

Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19

Zach Henderson, Chief Commercial Officer, Glooko As with so many aspects of our daily lives, the impact of the COVID-19 pandemic on clinical trials was both widespread and monumental. Thousands of trials—an estimated 80% of non-COVID-19 trials—came to a halt or were interrupted by the pandemic, which challenged the ability to conduct trials safely and …

Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19 Read More »

Philips, Disney Partner to Improve Pediatric Experience During MRI Exams

What You Should Know: – Philips and Walt Disney Company, today announced a partnership partners to conduct first of its kind clinical research pilot program that aims to help reduce fear and anxiety to improve children’s patient experience during MRI exams – As part of the partnership, Philips will investigate how Philips Ambient Experience – …

Philips, Disney Partner to Improve Pediatric Experience During MRI Exams Read More »

Increasing patient engagement with UK clinical trials

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Patient engagement can help address long-running industry issues, such as recruitment and retention, as well as reducing the need for additional trial …

Increasing patient engagement with UK clinical trials Read More »

Verily and Janssen Launch COVID-19 Immune Response Study

What You Should Know: – Verily and Janssen launches COVID-19 Immune Response Study that aims to collect detailed information about how the coronavirus affects the immune system immediately after someone tests positive for COVID-19. Verily, an Alphabet company, is partnering with Janssen Research & Development LLC (Janssen) to launch a COVID-19 Immune Response Study as …

Verily and Janssen Launch COVID-19 Immune Response Study Read More »

Clinical research in 2021: A new era of collaboration and innovation

The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. Worldwide Clinical Trial’s Aman Khera gives five predictions of how clinical research could change in 2021. The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and …

Clinical research in 2021: A new era of collaboration and innovation Read More »

Coordinating and delivering research in the pandemic: The UK approach

The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical research at a time of immense pressure and stress on personnel and resources. It triggered a system-wide response which took the UK’s collaborative culture to new levels. This multi-agency approach enabled unprecedented speed and efficiency in trial …

Coordinating and delivering research in the pandemic: The UK approach Read More »

Why Hospitals Should Act Now to Create Clinical AI Departments

John Frownfelter, MD, FACP, Chief Medical Information Officer at Jvion A century ago, X-rays transformed medicine forever. For the first time, doctors could see inside the human body, without invasive surgeries. The technology was so revolutionary that in the last 100 years, radiology departments have become a staple of modern hospitals, routinely used across medical …

Why Hospitals Should Act Now to Create Clinical AI Departments Read More »

Frenova Begins Patient Enrollment to Build World’s Largest Genomics Registry for Kidney Disease

What You Should Know: – Frenova Renal Research, a global division of Fresenius Medical Care, announced today that it has started to enroll patients in its new endeavor to build the world’s largest genomics registry targeting kidney disease. – The registry will be used to help advance understanding of the genetic drivers of kidney disease and …

Frenova Begins Patient Enrollment to Build World’s Largest Genomics Registry for Kidney Disease Read More »

30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021

As we close out the year, we asked several healthcare executives to share their predictions and trends for 2021. Kimberly Powell, Vice President & General Manager, NVIDIA Healthcare Federated Learning: The clinical community will increase their use of federated learning approaches to build robust AI models across various institutions, geographies, patient demographics, and medical scanners. The sensitivity and …

30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 Read More »

M&A: Philips Acquires Remote Cardiac Monitoring BioTelemetry for $2.8B

What You Should Know: – Philips acquires BioTelemetry, a U.S. provider of remote cardiac diagnostics and monitoring for $72.00 per share for an implied enterprise value of $2.8 billion (approx. EUR 2.3 billion). – With $439M in revenue in 2019, BioTelemetry annually monitors over 1 million cardiac patients remotely; its portfolio includes wearable heart monitors, …

M&A: Philips Acquires Remote Cardiac Monitoring BioTelemetry for $2.8B Read More »

VHA Innovation Ecosystem Taps MDClone to Leverage Synthetic Data for Faster Healthcare to Veterans

What You Should Know: – Data analytics and digital health company MDClone announced a partnership with the Department of Veterans Affairs’ (VA) VHA Innovation Ecosystem to democratize data and provide better, smarter, faster healthcare to U.S Veterans. – By leveraging MDClone’s data platform, the VHA is able to tackle this massive problem by securely accessing, …

VHA Innovation Ecosystem Taps MDClone to Leverage Synthetic Data for Faster Healthcare to Veterans Read More »

M&A: Cerner to Acquire Health Division of Kantar for $375M in Cash

What You Should Know:  – Cerner announces it will acquire Kantar Health, a leading data, analytics, and real-world evidence and commercial research consultancy serving the life science and health care industry. – This acquisition is expected to allow Cerner’s Learning Health Network client consortium and health systems with more opportunities to directly engage with life …

M&A: Cerner to Acquire Health Division of Kantar for $375M in Cash Read More »

Cerner Invests in Elligo to Make Clinical Trials Accessible for Health Systems of All Sizes

What You Should Know: – Cerner announced a strategic investment in Elligo Health Research, a leading research organization that enables clinical trials with nationwide community-based health care practices. – Cerner plans to expand the data and tools available in the Cerner Learning Health Network to offer additional clinical trial resources to community and rural hospitals …

Cerner Invests in Elligo to Make Clinical Trials Accessible for Health Systems of All Sizes Read More »

Medidata Acquires Digital Biomarker Business of MC10 / Clinical Trials & Wearable Sensors

What You Should Know: – Clinical trials technology company Medidata has acquired the digital biomarker business of MC10. – MC10’s offerings will bring novel clinical analytics and biosensor capabilities to Medidata’s existing technology solutions, enhancing Medidata’s capabilities to integrate data from wearable sensors – including clinical grade metrics – in clinical trials. – With this …

Medidata Acquires Digital Biomarker Business of MC10 / Clinical Trials & Wearable Sensors Read More »

Intermountain, Sanford Health Signs Intent to Merge

What You Should Know: – Intermountain Healthcare and Sanford Health sign a letter of intent to merge that will created a combined health system employing more than 89k people at 70 hospitals and 435 clinics across seven states. Intermountain Healthcare and Sanford Health, one of the nation’s leading systems in rural health care delivery and …

Intermountain, Sanford Health Signs Intent to Merge Read More »

Castor Raises $12M to Advance COVID-19 Research Through Clinical Trial and Data Automation

What You Should Know: – Castor raises $12M in Series A funding to further their support for COVID-19 research through clinical trial and data automation. – With 4,000 live studies and 2,000,000 enrolled patients across 90 countries, Castor will use the funding to further invest in enabling patient-centric, data-powered clinical trials. Castor, a Hoboken, New …

Castor Raises $12M to Advance COVID-19 Research Through Clinical Trial and Data Automation Read More »

Decentralised trials – aided by tech – could boost clinical research

Bringing clinical trials to patients – rather than the reverse – could be the key to improving recruitment into studies and making them faster, cheaper and more likely to succeed, according to one clinical research organisation (CRO). There’s already plenty of support from regulators for virtual or ‘decentralised’ trials, including from former FDA Commissioner Scott …

Decentralised trials – aided by tech – could boost clinical research Read More »

Ciox Health Acquires Biomedical NLP Company Medal

What You Should Know: – Ciox Health has acquired Medal, Inc., a biomedical Natural Language Processing (biomed-NLP) technology company. – The acquisition will lead Ciox to better and more quickly enable real-world data in support of research that advances patient care. Ciox Health, a leading health technology company, today announced its acquisition of San Francisco-based biomedical Natural Language …

Ciox Health Acquires Biomedical NLP Company Medal Read More »

10 Healthcare Innovations That Can Reduce Total Disease Burden 6-10% by 2040

What You Should Know: –  40 percent of the global disease burden could be addressed with known interventions, but that leaves 60 percent unaddressed. – As part of the recent McKinsey report Prioritizing health: A prescription for prosperity, the McKinsey Global Institute identified ten promising innovations that can reduce total disease burden 6-10% by 2040. …

10 Healthcare Innovations That Can Reduce Total Disease Burden 6-10% by 2040 Read More »